Bgm Group Ltd Quick Ratio (BGM) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bgm Group Ltd  (BGM)

Bgm Group Ltd's Quick Ratio

BGM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 0.24 a new company low.

Within Major Pharmaceutical Preparations industry 486 other companies have achieved higher Quick Ratio than Bgm Group Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 2633 to 3614.

Explain Quick Ratio?
How much Cash & cash equivalents BGM´s has?
What are BGM´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BGM Quick Ratio (Sep 30 2025)
Q4		 (Mar 31 2025)
Q3		 (Sep 30 2024)
Q2		 0
Q1		 0
Q4
Y / Y Current Liabilities Change 373.99 % 240.51 % 60.1 % 66.09 % 60.1 %
Y / Y Cash & cash equivalent Change 0.02 % 13.87 % 15.82 % 15.82 % 15.82 %
Quick Ratio MRQ 0.24 0.54 1.12 1.12 1.12
BGM's Total Ranking # 3614 # 2633 # 1689 # #
Seq. Current Liabilities Change 131.2 % 105.01 % 0 % 0 % 66.09 %
Seq. Cash & cash equivalent Change 1.74 % -1.69 % 0 % 0 % 15.82 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 487
Healthcare Sector # 931
Overall Market # 3614


Quick Ratio Statistics
High Average Low
1.6 1.08 0.24
0   (Sep 30 2025)




Financial Statements
Bgm Group Ltd's Current Liabilities $ 42 Millions Visit BGM's Balance sheet
Bgm Group Ltd's Cash & cash equivalent $ 10 Millions Visit BGM's Balance sheet
Source of BGM's Sales Visit BGM's Sales by Geography


Cumulative Bgm Group Ltd's Quick Ratio

BGM's Quick Ratio for the trailling 12 Months

BGM Quick Ratio

 (Sep 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Sep 30 2024)
12 Months		 0
12 Months		 0
12 Months
Y / Y Current Liabilities TTM Growth 210.74 % 105.85 % 21.02 % -5.04 % -27.85 %
Y / Y Cash & cash equivalent TTM Growth 10.95 % 15.33 % -4.58 % -19.75 % -31.47 %
Quick Ratio TTM 0.51 0.88 1.2 1.29 1.42
Total Ranking TTM # 3989 # 3904 # 3321 # #
Seq. Current Liabilities TTM Growth 74.06 % 40.2 % 11.63 % 14.07 % 15.3 %
Seq. Cash & cash equivalent TTM Growth 0.01 % 3.1 % 3.67 % 3.8 % 3.96 %

Quick ratio ranking by company, industry and sector >> Back to BGM Financial Strength Comparisons >> Go to Compare BGM Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2025 to $41.60 millions, cumulative Quick Ratio decreased to 0.51 below the Bgm Group Ltd average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 485 other companies have achieved higher Quick Ratio than Bgm Group Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 3904 to 3989.

Explain Quick Ratio?
How much Cash & cash equivalents BGM´s has?
What are BGM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 486
Healthcare Sector # 1013
Within the Market # 3989


trailing twelve months Quick Ratio Statistics
High Average Low
1.56 1.24 0.58
(Sep 30 2022)   (Sep 30 2021)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Enlivex Therapeutics Ltd  0.64 $ 5.755  Millions$ 9.021  Millions
Merck and Co Inc   0.64 $ 18,214.000  Millions$ 28,628.000  Millions
Cumberland Pharmaceuticals Inc   0.64 $ 15.197  Millions$ 23.909  Millions
Collegium Pharmaceutical Inc   0.63 $ 285.863  Millions$ 452.929  Millions
Lifecore Biomedical Inc   0.63 $ 18.856  Millions$ 29.958  Millions
Johnson and Johnson  0.63 $ 18,562.000  Millions$ 29,513.000  Millions
Journey Medical Corp  0.63 $ 24.948  Millions$ 39.715  Millions
Heron Therapeutics Inc   0.62 $ 55.487  Millions$ 89.708  Millions
Bristol myers Squibb Company  0.59 $ 16,502.000  Millions$ 28,136.000  Millions
Aurinia Pharmaceuticals Inc   0.58 $ 72.889  Millions$ 124.931  Millions
Jazz Pharmaceuticals Plc  0.58 $ 1,326.070  Millions$ 2,274.102  Millions
Ironwood Pharmaceuticals inc   0.58 $ 140.407  Millions$ 242.503  Millions
Ascendis Pharma A  0.58 $ 691.961  Millions$ 1,197.718  Millions
Galapagos Nv  0.57 $ 98.412  Millions$ 171.207  Millions
Phibro Animal Health Corporation  0.57 $ 85.273  Millions$ 149.041  Millions
Assertio Holdings inc   0.56 $ 93.427  Millions$ 166.783  Millions
Karyopharm Therapeutics Inc   0.53 $ 45.877  Millions$ 87.157  Millions
Nls Pharmaceutics Ltd  0.52 $ 2.201  Millions$ 4.195  Millions
Apollomics Inc   0.52 $ 3.276  Millions$ 6.326  Millions
Aytu Biopharma Inc  0.49 $ 32.630  Millions$ 65.993  Millions
Elanco Animal Health Incorporated  0.47 $ 505.000  Millions$ 1,079.000  Millions
Omeros Corporation  0.45 $ 36.085  Millions$ 80.756  Millions
Eli Lilly And Company  0.44 $ 9,913.500  Millions$ 22,520.700  Millions
Genprex Inc   0.43 $ 1.103  Millions$ 2.552  Millions
Novartis Ag  0.43 $ 11,640.000  Millions$ 27,278.000  Millions
Indivior Pharmaceuticals Inc   0.42 $ 445.000  Millions$ 1,048.000  Millions
Perrigo Company Plc  0.42 $ 432.100  Millions$ 1,035.400  Millions
Grifols Sa  0.42 $ 943.040  Millions$ 2,261.280  Millions
Cormedix Inc   0.42 $ 55.717  Millions$ 133.644  Millions
Pfizer Inc  0.41 $ 14,984.000  Millions$ 36,596.000  Millions

Date modified: 2026-09-08T15:11:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.